Unifers.ai

Scott Knapp

Commercial Business Director, East (Saphnelo and Fasenra) @AstraZeneca

Albany, NY, US
EMAILS
s••••••••@astrazeneca.com
MOBILE NUMBERS
+15•••••••74

Signup · Get unlimited contacts

WORK HISTORY

Oct 2020 — Present

Commercial Business Director, East (Saphnelo and Fasenra) @AstraZeneca

View department →

Wilmington, DE, US

Second-line Immunology Sales Leader for Eastern portion of the United States currently leading a team of 6 district managers and 60 sales professionals that promote a first in class IFN biologic for Lupus (SLE) and an IL-5 biologic for EGPA to Rheumatologists.

EDUCATION

1997 — 2001

Siena University

Bachelor of Science (BS), Finance, General

2008 — 2009

Norwich University

Master of Business Administration (MBA), Business Administration and Management, General

SKILLS

MarketingSelling SkillsAccount ManagementLeadershipPharmaceutical IndustrySellingPublic SpeakingGroup PresentationsCustomer SatisfactionNew Business DevelopmentBuilding RelationshipsStrong Business AcumenTeam LeadershipEndocrinologyCollaborativeStrategic PlanningSales PresentationsSales EffectivenessManagementOb/GynBuyMarketing StrategyCrmNew Business OpportunitiesNephrologyOsteoporosisSales ProcessCardiologyIdentifying New Business OpportunitiesNeurologyRheumatologyProduct LaunchSales OperationsBuyPharmaceutical Sales

ABOUT SCOTT KNAPP

Highly analytical and driven 2nd-line biologic sales leader who is currently leading a Rheumatology sales team in the Lupus SLE therapeutic area with Saphnelo (IFN biologic) and EGPA with Fasenra (IL-5 biologic). 2023 Circle of Excellence winner. Previously worked at Sanofi Genzyme on the multi-indication blockbuster, Dupixent (IL4/13 biologic). Prior to that, I was at Novartis working on the Cosentyx (IL17 biologic), Reclast, Diovan, Exelon Patch, and Tekturna brands.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.